Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 86 | 72 | 72 | 72 | 72 |
| Gross Profit | 86 | 72 | 72 | 72 | 72 |
| Operating Expenses | 83,566 | 72,259 | 55,969 | 71,550 | 51,296 |
| Operating Income | -83,480 | -72,187 | -55,897 | -71,478 | -51,224 |
| Interest Expense | 529 | 597 | 587 | 400 | 600 |
| Other Income | 7,320 | 7,791 | 7,942 | 5,018 | 4,164 |
| Pre-tax Income | -76,689 | -64,993 | -48,542 | -66,860 | -47,660 |
| Net Income Continuous | -76,689 | -64,993 | -48,542 | -66,860 | -47,660 |
| Net Income | $-76,689 | $-64,993 | $-48,542 | $-66,860 | $-47,660 |
| EPS Basic Total Ops | -0.88 | -0.77 | -0.59 | 0.06 | -1.09 |
| EPS Basic Continuous Ops | -1.15 | -1.02 | -0.79 | -1.33 | -1.09 |
| EPS Diluted Total Ops | -0.88 | -0.77 | -0.59 | 0.06 | -1.09 |
| EPS Diluted Continuous Ops | -1.15 | -1.02 | -0.79 | -1.33 | -1.09 |
| EPS Diluted Before Non-Recurring Items | -1.15 | -1.02 | -0.79 | N/A | N/A |
| EBITDA(a) | $-86,727 | $-76,576 | $-60,292 | $-74,395 | $-53,628 |